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ABSTRACT
Central memory (TCM) CD4
 T cells are the principal reservoir of latent HIV-1 infection that persists despite durable, successful
antiretroviral therapy (ART). In a study that measured HIV DNA in 17 patients and replication-competent HIV in 4 patients,
pools of resting and activated transitional memory (TTM) CD4
 T cells were found to be a reservoir for HIV infection. As defec-
tive viruses account for the majority of integrated HIV DNA and do not reflect the actual frequency of latent, replication-compe-
tent proviral infection, we assessed the specific contribution of resting TTM cells to latent HIV infection. We measured the fre-
quency of replication-competent HIV in purified resting memory cell subpopulations by a limiting-dilution, quantitative viral
outgrowth assay (QVOA). HIV was routinely detected within the resting central memory compartment but was infrequently
detected within the resting TTM compartment. These observations suggest that prolonged ART may limit persistent latent infec-
tion in the TTM compartment. Our results confirm the importance of latent infection within the TCM compartment and again
focus attention on these cells as the most important latent viral reservoir. While proliferation may drive expansion of detectable
viral genomes in cells, the frequency of replication-competent HIV must be carefully assessed. Latent infection appears to wane
within the transitional memory compartment in patients who have sustained successful viral suppression via ART or were
treated very early in infection.
IMPORTANCE
Antiretroviral therapy (ART) has led to a significant decrease in morbidity and mortality among HIV-infected patients. How-
ever, HIV integrates into the genome of CD4 T cells, generating pools of long-lived cells that are reservoirs of latent HIV. Two
main subsets of CD4 T cells, central memory and transitional memory cells, were reported to be major reservoirs of HIV infec-
tion. However, this study primarily measured the HIV DNA content, which also includes defective proviruses that would not be
able to replicate and initiate new rounds of infection. By analyzing the replication-competent virus in both cell subsets, we
showed that transitional memory cells may not be a durable reservoir in patients on successful ART.
After HIV infection, there may be several pathways that lead toproviral latency. Most latent infection may be established in
activated CD4 T cells that transition to the memory resting state
shortly after infection (1). Mechanisms that maintain latent infec-
tion are operable in cells that are in a resting G0 state (2). When the
cells are resting, HIV persists but is transcriptionally silent, invis-
ible to immune surveillance, and insensitive to antiretroviral ther-
apy (ART) (3–5). The major cellular reservoir of quiescent but
replication-competent viruses that persists despite ART resides in
a small pool of resting memory CD4 T cells (2, 6–10). Previous
analysis found that frequencies of HIV DNA within activated cells
are dramatically higher than within cells in a resting state, reflect-
ing rapid death of activated cells and suggesting that only a frac-
tion of productively infected activated cells survive to return to the
memory resting state (2). Therefore, activated cells do not consti-
tute a stable population in which HIV can persist for years. The
definition of subpopulations of resting cells that harbor latent
infection that can persist despite durable ART is of critical impor-
tance.
A previous study of CD4 T cells, in which populations were
studied irrespective of their activation state, found that central
memory (TCM) and transitional memory (TTM) CD4
 T cell sub-
sets were the major reservoirs for HIV infection (11). It was pro-
posed that latent infection was maintained by either antigen-
driven proliferation or homeostatic proliferation in TCM or TTM
cells, respectively (11). In a more recent study, HIV DNA was also
detected in both resting TCM and TTM CD4
 T cells in viremic
patients (12). However, the contribution of replication-compe-
tent virus within resting TCM and resting TTM cells to the total HIV
reservoir in patients with complete suppression of plasma viremia
has not been addressed. This is a critical point, given the potential
for some cell populations to proliferate and as the majority of HIV
DNA detected in resting CD4 T cells consists of defective, non-
replication-competent genomes (2, 13, 14). In addition, the im-
pact of immediate or delayed ART on the distribution of persis-
tent, latent infection in CD4 T cell subpopulations is not known.
Furthermore, inherent differences in biologically distinct reser-
voirs might influence the design of therapeutic interventions to
target TTM CD4
 T or TCM CD4
 T cells.
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In the present study, we analyzed the frequency of latent HIV
infection in highly purified, resting TCM and TTM CD4
 T cells by
a quantitative viral outgrowth assay (QVOA) (15–17) comparing
a cohort of patients treated during acute HIV infection (AHI) with
patients treated during chronic HIV infection (CHI). We also
measured the frequency of HIV infection within naive CD4 T
cells. Our results show that HIV latency is primarily established
and maintained in TCM CD4
 T cells and that latency is found in
TTM CD4
 T cells in a minority of patients. Our findings suggest
that while latent infection may be established within TTM CD4
 T
cells, initially supported by homeostatic proliferation, the admin-
istration of durable ART allows the decay of infection within this
cell population.
MATERIALS AND METHODS
Patients. All patients provided written informed consent, and studies
were approved by the UNC Institutional Review Board. Patients identified
in the AHI stage (plasma HIV RNA detected and HIV Western blot neg-
ative) were enrolled and initiated ART within 45 days of the estimated
date of infection; most patients were treated within 3 weeks of the esti-
mated date of infection. Serial measurements of plasma viremia and
CD4 T cell counts were performed, and when patients were aviremic
(50 HIV RNA copies/ml) on ART for 2 years, cells were obtained by
continuous-flow leukapheresis.
Isolation of resting memory CD4 T cell subpopulations and naive
CD4 T cells. Total resting CD4 T cells were isolated from the leu-
kapheresis product as previously described (1, 15–17). Following purifi-
cation, resting CD4 T cells were incubated for 1 day with the HIV inte-
grase inhibitor L-870812 (1 M; gift of D. Hazuda, Merck Research
Laboratory, West Point, PA) and efavirenz (15 nM) or abacavir (4 M) as
determined by treatment history to ensure the decay of any preintegrated
HIV DNA and to avoid any potential de novo infection during cell
isolation. Total resting CD4 T cells were then enriched for memory
cells by magnetic separation using a custom cocktail containing
CD45RA monoclonal antibody (MAb; Stemcell Technologies, Van-
couver, Canada). Afterwards, enriched resting memory CD4 T cells
were incubated in staining buffer with CD45RA-fluorescein isothio-
cyanate (FITC) and CD4-peridinin chlorophyll protein (PerCP) Cy5.5
(clone HI-100 and clone SK3; BD Pharmingen, San Diego, CA), and
CD27-phycoerythrin (PE) and CCR7-allophycocyanin (APC) (clone
O323 and clone G043H7; Biolegend, San Diego, CA), for 20 min on ice
in the dark, washed twice, resuspended in a phosphate-buffered saline
(PBS)-EDTA-HEPES solution, filtered, and isolated by fluorescence-
activated cell sorting (FACS) using a Reflection sorter (iCyt, Cham-
pagne, IL) or a FACSAria III (BD Biosciences, San Jose, CA). Resting
memory CD4 T cell subsets were defined as CD4 CD45RA. TCM
CD4 T cells were gated based on their expression of CD27 and CCR7,
while TTM CD4
 T cells were defined as CD27 CCR7. Naive CD4
T cells were CD45RA CD27 CCR7. Each experiment was validated
by performing instrument quality controls and running isotype con-
trols and fluorescence minus one control. Cells were collected in Is-
cove’s modified Dulbecco’s medium (IMDM) containing HEPES and
glutamine (Gibco, Invitrogen, Carlsbad, CA) and 10% fetal bovine
serum (FBS) and 10% penicillin-streptomycin (PenStrep) (both from
Sigma-Aldrich, St. Louis, MO). After sorting, an aliquot was used to
assess the purity of the sorted T cell subsets, which was 99% (see
Fig. 1).
Quantitative viral outgrowth assay. After sorting, resting memory
CD4 T cell subsets and naive cells were cultured in Complete IMDM
(cIMDM; containing the supplements HEPES, Gln, 10% FBS, and Pen-
Strep) and activated as previously reported for total resting CD4 T cells
(17). Briefly, 2.5  106 to 2.5  104 CD4 T cells of each subset were
cultured in limiting dilution in the presence of 1 g/ml of phytohemag-
glutinin (PHA), 60 U/ml of interleukin 2 (IL-2), and allogeneic irradiated
peripheral blood mononuclear cells (PBMC) for 24 h. Cells were then
washed and resuspended in cIMDM with 5 U/ml of IL-2. Allogeneic non-
infected PBMC depleted of CD8 T cells and activated by PHA were used
as target cells at a 1:5 ratio (CD4 T cells/PBMC). Cultures of total resting
CD4 T cells from the same patient were performed in parallel. Medium
was replaced every 3 to 4 days. At days 15 and 19 of culture, supernatants
were collected and stored at 80°C until further p24 production analysis














AHI A.1 289 5.13 674 3.61 2.91
A.2 403 5.88 730 4.45 3.75
A.3 371 5.19 629 3.38 3.22
A.4 137 6.24 776 4.04 3.12
A.5 739 4.39 1,378 3.89 3.78
A.6 500 6.26 723 2.78 3.59
A.7 606 6.06 940 1.02 0.99
A.8 520 4.36 698 0.97 0.76
A.9 504 5.77 1,355 2.08 1.82
Median 137 5.76 730 3.88 3.12
CHI C.1 NAb NA 711 8.48 3.31
C.2 130 5.24 903 18.90 10.62
C.3 81 5.58 772 12.52 2.76
C.4 195 4.86 1,027 26.93 7.50
C.5 322 5.57 830 3.09 2.79
C.6 602 5.88 1,120 5.39 5.06
C.7 166 5.77 474 2.54 1.99
Median 180.5 5.57 830 8.48 3.31
P valuec 0.059 0.79 0.03 0.26
a Peak of HIV-1 plasma viral load (VL) in the acute phase of the infection for AHI patients and highest plasma viral load on our records for CHI patients.
b NA, not available.
c Determined by Mann-Whitney U test.
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by a commercially available enzyme-linked immunosorbent assay
(ELISA) kit (ABL Inc., Rockville, MD). We scored cultures as positive if
p24 was detectable 15 days after cell culture, and rising p24 concentrations
were confirmed on day 19.
Total HIV DNA quantification. Resting memory CD4 T cell subsets
and TCM, TTM, and naive cells were isolated from frozen PBMC, pelleted,
and stored at 80°C until DNA extraction was performed. Cellular DNA
was extracted using a Qiagen DNA minikit by following the manufactur-
er’s instructions. DNA concentration was measured using a Nanodrop.
HIV pol DNA was amplified and droplet digital PCR (ddPCR) performed
as previously described (18). Briefly, PCR samples were loaded into the
Bio-Rad QX emulsification device and droplets were formed by following
the manufacturer’s instructions. After 40 cycles of 30 s at 94°C, 60 s at
58°C, and 10 min at 98°C, droplets were analyzed as positive or negative,
with the no-template controls serving as the threshold of the limit of
quantification, and copy number was calculated by the manufacturer’s
software (Bio-Rad Quantasoft v.1.2).
Statistical analyses. Results are expressed as medians and interquar-
tile ranges (IQ). Nonparametric tests were used for analyses, and P values
of 0.05 were considered significant. Differences between categorical
groups were compared using the two-tailed Mann-Whitney U test, and
correlations between continuous variables were performed by Spearman’s
test. Estimated frequency of infection in different T cell subsets is ex-
pressed as infectious units per million (IUPM) cells, estimated by a max-
imum likelihood method (15). Statistical analyses were performed using
IBM SPSS version 19.0 (Chicago, IL).
RESULTS
Patient characteristics. Sixteen male patients, nine patients
treated during AHI and seven treated during CHI, were included
in the present study. The median age was 37 (range, 27 to 51)
years. Nine (56%) patients were Caucasian, six (37%) were Afri-
can-American, and one (6%) patient was Hispanic. Of central
importance, patients had been treated for a median of 3.7 (range,
2.6 to 7.8) years and had been suppressed (plasma HIV-1 RNA 
50 copies/ml) for a median of 3.2 (range, 2.2 to 3.8) years; there-
fore, the virological events measured reflect those that persist de-
spite durably successful ART. The median CD4 T cell nadir was
371 (range, 166 to 520) cells/mm3, and the median CD4 T cell
count at the time of cell donation for QVOA was 774 (range, 701
to 1,005) cells/mm3. In addition, at the time of the study, clinical
comparisons between patients treated during AHI or CHI showed
no statistical differences except that the length of time that pa-
tients had been on therapy was longer for CHI patients (P  0.03),
but the durations of full suppression were similar (P  0.26) (Ta-
ble 1).
TCM CD4
 T cells are the major reservoir for HIV infection.
Replication-competent HIV was measured by QVOA within total
resting memory CD4 T cells in all 16 patients and within sepa-
rated memory CD4 T cell subpopulations (Table 2). Cell popu-
lations were rigorously processed to high purity (Fig. 1) in the
presence of antiretrovirals during processing and sorting to pre-
vent spread of infection and the factitious amplification of infec-
tion within subpopulations.
In two patients treated during AHI (A.3 and A.5), latent infec-
tion was not detected in total resting CD4 T cells, but it was
detected within the subpopulation of purified TCM cells as a result
of the enrichment of TCM cells, which harbor the majority of the
replication-competent HIV. As the majority of patients had pre-
served CD4 cell counts (Table 1), the frequency of replication-
competent HIV in total resting CD4 T cells did not correlate with
CD4 T cell counts at the time of leukapheresis (P  0.53). How-
ever, in AHI patients the CD4 T cell nadir was inversely corre-
lated with the infectious units per million (IUPM) total resting
CD4 T cells (P  0.02; R  0.748).
The median numbers of TCM CD4
 T cells cultured were
22.5 million (range, 11.6 to 28.5 million) in patients who
started ART during AHI and 12.0 million (range, 1.0 to 30.0
million) in patients who started ART once CHI was established.
Likely due to the smaller cohort size, there was only a trend
toward a lower frequency of latent infection in AHI patients
than in CHI patients (P  0.05), unlike what has been previ-
ously reported (1–3). Replication-competent HIV was quanti-
fiable in the TCM CD4
 T cell subset for all patients but one
(C.1), in whom infection in the total memory CD4 cell popu-
lation was rare (IUPM  0.02 [Table 2]). The frequency of
latent infection in TCM CD4
 T cells showed a strong positive
TABLE 2 Frequency of infection within resting memory CD4 T cells
Patient











A.1 2.31 4.26 2.15 NA
A.7 0.90 2.07 3.74 NA
A.8 0.74 5.89 4.52 NA
A.4 7.69 3.41 2.68 NA
A.3 0.10 0.16 0.16 NA
A.2 0.41 0.85 1.91 5.1
A.6 0.04 0.47 4.05 12
A.9 0.02 0.24 2.22 10.3
A.5 0.10 0.03 0.16 26.5
C.7 0.44 3.67 2.23 416.7
C.6 0.61 2.06 4.05 LOQ
C.2 0.18 0.53 1.62 LOQ
C.1 0.02 1.39 2.23 LOQ
C.5 3.75 9.74 10.9 NA
C.3 2.69 4.23 2.72 NA
C.4 0.11 0.77 1.82 NA
a LOQ, limit of quantification; NA, not available.
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correlation with the frequency of infection in total resting
CD4 T cells (P  0.001; R  0.928), showing that the TCM
CD4 T cell subset harbored the majority of replication-com-
petent HIV, regardless of the time of ART initiation (P  0.05).
Replication-competent HIV is infrequently recovered from
resting TTM cells. Resting TTM CD4
 T cells were simultaneously
purified from the total memory pool, isolated, and cultured in
parallel with TCM cells to measure the frequency of latent but
replication-competent infection (Table 2). Our protocol for iso-
lating resting cells excludes cells displaying the activation markers
HLA-DR and CD25. As these markers may be expressed on a
portion of the TTM cells, we analyzed the percentage of these cells
that may have been excluded during the procedure for purifying
resting memory T cells (Fig. 2). In eight patients, the TTM CD4
 T
cells accounted for a mean of 6.46% of the CD3 CD4
CD45RA cell population, but of these cells, only a mean of 0.41%
displayed any of the activation markers HLA-DR, CD25, and
CD69. In addition, for one AHI patient who had been suppressed
for more than 5 years, we performed a QVOA using TTM cells
sorted according to HLA-DR expression, and we did not recover
any virus either from the total cell pool containing activated cells
or from the TTM pool that excluded the activated population (data
not shown).
In total, 0.2 to 7.5 million resting TTM CD4
 T cells from nine
AHI patients and 0.1 to 5.3 million resting TTM CD4
 T cells from
seven CHI patients were used for outgrowth assays. Surprisingly,
replication-competent HIV was quantifiable for only 5 of 16 pa-
tients, 3 treated during AHI and 2 treated during CHI (Table 2).
Interestingly, the three AHI patients in whom HIV was recovered
had been suppressed for a mean of 1.58 years, compared to a mean
of 3.21 years of suppression in patients with no replication-com-
petent HIV recovered. In addition, it was discovered that the two
CHI patients from whom replication-competent virus was recov-
ered had a history of poor therapy adherence with multiple epi-
sodes of ART interruption prior to meeting the adherence criteria
(uninterrupted successful ART for more than 2 years) that al-
lowed them to participate in this study. Given the lack of recovery
of replication-competent HIV within isolated TTM CD4
 T cells,
we attempted to measure total HIV DNA in eight patients (four
during AHI and four during CHI) in whom replication-compe-
FIG 1 Representative dot plot examples of presort gating strategy to isolate resting TCM cells (CD4
 CD45RA CD27 CCR7), resting TTM cells (CD4
 CD45RA
CD27 CCR7), and naive CD4 T cells (CD4 CD45RA CD27 CCR7) (A) and percentage of postsort purities in these three CD4 T subsets (B).
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tent HIV was not recovered. HIV DNA was detected in the four
patients treated during AHI and in only one treated during CHI,
while it was below the limit of detection in the other three CHI
patients (Table 2). As the number of TTM cells available to perform
limiting dilution outgrowth assays was less than that of TCM cells,
the ability to apply robust direct statistical comparisons between
the two groups was limited. However, overall, we performed 129
cultures of 30  106 TTM cells from all patients, and only 9 cultures
(6.9%) yielded replication-competent virus, while 132 of 442
(29.8%) were positive in the TCM compartment (Table 3). The
numbers of TTM culture replicates were comparable between pa-
tients with and without HIV recovery from TTM CD4
 T cells
(P  0.36).
Frequency of infection in resting TTM cells decays with lon-
ger duration of HIV plasma suppression. The frequency of infec-
tion in TTM CD4
 T cells positively correlated with the frequency
of infection in TCM CD4
 T cells (R  0.551; P  0.027), although
no correlation with total resting CD4 T cells was found (P 
0.05). We found an inverse correlation between the frequency of
infection within TTM CD4
 T cells and the duration of ART sup-
pression in patients who initiated treatment during AHI (R 
0.772; P  0.015) (see Fig. S1 in the supplemental material),
which did not achieve significance in patients treated during CHI
(P  0.05). In addition, we also found an inverse correlation be-
tween HIV DNA levels within resting TTM cells and the duration
the patients had been on therapy (R  0.805; P  0.016). These
preliminary results suggest that resting cell infection in TTM de-
cays over time, at least in patients treated during AHI.
Latently infected naive CD4 T cells are found in both AHI
and CHI patients. In 11 of 16 patients, sufficient cells were avail-
able to isolate and study latent HIV infection in naive CD4 T
cells. A median of 3.6 million naive cells (range, 2.3 to 9.0 million)
were cultured, revealing replication-competent HIV in four pa-
tients, two of six treated during AHI (A.4 and A.6) and two of five
treated during CHI (C.3 and C.6). It is notable that the two AHI
patients had the highest levels of peak of viremia prior to therapy
recorded in our cohort, and the two CHI patients had the highest
levels of set point viremia prior to ART in this cohort (Table 1),
suggesting that latent infection of naive cells may be associated
with particularly poor immune control of HIV replication.
FIG 2 To illustrate the frequency of activated cells within the memory population, a representative example for one patient is shown within either total
CD45RA CD3 CD4 cells without excluding activated cells, defined by a combination of activation markers HLA-DR, CD25, and CD69 (A), or within the
nonactivated CD45RA CD3 CD4 compartment (B). In this patient, only 0.5% of the TTM cells display activation markers.













Total no. of cells
cultured
TCM 275 78 (28.4) 139  10
6 167 54 (32.3) 114  106
TTM 70 6 (8.6) 17  10
6 59 3 (5.1) 13  106
Naive 91 3 (3.3) 38  106 91 18 (19.7) 25  106
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DISCUSSION
This is the first study that has exhaustively analyzed the frequency
of replication-competent HIV using QVOA within resting mem-
ory CD4 T cell subpopulations. In striking distinction to the
uniform recovery of latent HIV from resting TCM cells, we did not
recover replication-competent HIV from pools of resting TTM
CD4 T cells in 11 out of 16 patients that had been durable sup-
pressed by ART without interruptions for 2 years or more. This
highlights an important distinction between latent infection of
TTM and TCM cells and suggests that latent, replication-competent
HIV infection does not persist uniformly in the resting TTM pop-
ulation in patients undergoing ART.
TTM CD4
 T cells can harbor high levels of HIV DNA in some
patients (Table 2 and reference 11). However, current measure-
ments of replication-competent HIV show that TCM CD4
 T cells
are the major latent reservoir after initiation of ART in either the
acute or the chronic stage of infection. We detected HIV DNA
within resting TTM CD4
 T cells in patients with no replication-
competent virus recovery, suggesting an excess of non-replica-
tion-competent HIV as demonstrated by Chun et al. (2) and re-
cently reexamined in careful studies by Ericksson et al. (19) and
Ho et al. (20). Although other studies have detected HIV DNA in
TTM CD4
 T cells (12), these patients were viremic and so latent
DNA genomes could not be distinguished from defective genomes
or genomes actively expressing viral RNA. Studies that do not
exclude activated CD4 T cells may detect a less stable reservoir
(2, 21), which may decay on durable therapy, as suggested by our
results. In this study, we used the CD25 marker to exclude acti-
vated T cells. However, there is a subset of resting memory CD4
T cells that express intermediate levels of CD25 (22), so this pop-
ulation merits further analysis.
Homeostatic proliferation of TTM CD4
 T cells has the poten-
tial to maintain the presence of replication-competent, integrated
HIV DNA in TTM CD4
 T cells (11). We found a strong correla-
tion between longer duration of suppression of viremia and a
lower frequency of infection within resting TTM CD4
 T cells in
patients treated during AHI, an aspect also supported by the in-
verse correlation between HIV DNA within TTM cells and the time
patients had been on therapy. However, this preliminary observa-
tion must be confirmed by including more patients. Our results
suggest that while homeostatic proliferation of resting memory
TTM CD4
 T cells may contribute to the accumulation and main-
tenance of latent HIV genomes within TTM CD4
 T cells during
the initial months of ART, this influence appears to wane, and
replication-competent HIV within resting TTM appears to decay.
One recent study supports our results showing expansion of T cell
clones containing defective non-replication-competent HIV over
time (23). In another study, HIV DNA sequences were signifi-
cantly increased after long-term suppressive ART (24), consistent
with our findings that nondefective viruses may accumulate
within the TTM compartment. We were able to quantify HIV DNA
in TTM CD4
 T cells in all patients analyzed, but replication-
competent virus was infrequently recovered. Moreover, we had
the opportunity to analyze the frequency of infection in the resting
TTM compartment in patient A.7 1 year following the initial
QVOA measurement, finding a decay in the frequency of infection
in total resting CD4 T cells (from 0.902 to 0.496 IUPM cells) and
in TCM CD4
 T cells (from 2.070 to 0.747 IUPM cells), with no
virus recovered in TTM CD4
 T cells (3.74 declined to 2.23). Our
findings are consistent with a model in which latent infection is
established within TTM cells but decays on ART, as it does in the
first few years of ART (9, 10). Moreover, the only two CHI patients
in whom HIV was recovered within TTM cells had a history of poor
adherence to ART with several treatment interruptions, suggest-
ing reseeding of the TCM and TTM pools prior to the period of
adherence (more than 3 years) that allowed them to be enrolled in
this study. Taken together, our results show that TTM CD4
 T cells
are not a major reservoir for HIV infection in durably suppressed
patients on ART and suggest that while infection of this popula-
tion can occur, it may not be long-lived. The decline of infection in
TTM CD4
 T cells is consistent with this hypothesis. All patients
but one included in our study had normal numbers of CD4 T
cells at the time of leukapheresis, due to early or durable and
successful ART. In contrast to the previously reported patient
population still undergoing CD4 reconstitution (11), the popula-
tion reported herein had achieved stable CD4 T cell levels (or
never had CD4 depletion), and plasma IL-7 levels were therefore
not correlated with the CD4 counts or the frequency of infection
in the resting CD4 T cell populations (data not shown).
In addition, a previous study found that the proviral HIV DNA
level was predicted by CD4 T cell nadir (25). We also found that
when ART is initiated during AHI, the frequency of total resting
cell infection is correlated with the CD4 T cell nadir. One possi-
ble explanation for the lack of correlation in patients treated dur-
ing CHI is that while HIV DNA may accumulate over the time of
untreated HIV infection, and with higher levels of viremia, the
levels of true virologic latency reach an equilibration point and
HIV DNA does not accumulate continuously.
Limiting-dilution coculture of resting CD4 T cells utilizes a
protocol whereby cells are exposed to a single round of maximal
mitogenic stimulation. Ho et al. recently demonstrated that this
protocol may underestimate the frequency of replication-compe-
tent HIV (20), due to the stochastic nature of proviral activation
even in the face of maximal stimulation, and that virions may be
recovered from some cells in some patients with additional
rounds of stimulation. In our study, we compared the recovery of
latent HIV from resting TCM and TTM populations following a
single round of stimulation by the most sensitive assay available
(QVOA), using the largest number of cells that could be obtained
by apheresis. Assays of HIV DNA very significantly overrepresent
frequency of replication-competent proviral infection (2, 19). In
addition, HIV DNA/RNA ratio analyses may not accurately reflect
the frequency of latent, replication-competent infection due to the
potential presence of defective viral DNAs and RNAs (19). There-
fore, our assays, performed at the limit of what is currently tech-
nically feasible, show that latent infection within TTM populations
is less frequent and suggest that TTM infection decays over time
on ART.
We also detected replication-competent HIV in naive CD4 T
cells from four patients with poor initial immune control of
viremia during AHI, suggesting that innate immune responses in
early infection may play a critical role in limiting the establish-
ment of latent infection (26–28). Also, these results imply that
other mechanisms such as rapid innate immune responses, more
potent HIV-specific CD8 responses, or expression of specific pro-
tective alleles, such as HLA-B27/B57 (29), may, at least partially,
determine the size of the reservoir of replication-competent HIV.
Like for TTM cell populations, the uncommon detection of latent
infection in the naive cell population is consistent with latency in
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these cells being less durable than that in TCM cells, but confirma-
tion of this will require further longitudinal study. However, given
the recent description of a population of memory CD4 T cells
with stem cell properties (30) within which latent HIV may persist
(31), it should be noted that our method to isolate naive CD4 T
cells (CD45RA CD27 CCR7) might allow the inclusion of this
stem memory subset. Longitudinal study with careful quantita-
tion of replication-competent virus within stem-like CD4 mem-
ory cells will also be required.
In summary, our results demonstrate that replication-compe-
tent HIV is primarily found in resting TCM CD4
 T cells and
suggest that while homeostatic proliferation of infected resting
TTM CD4
 T cells may play a role in the maintenance of latent
infection within TTM cells, this effect may be of diminishing im-
portance over years of ART. Therefore, while approaches to de-
plete persistent infection based on the blockade of homeostatic
proliferation in TTM cells (32, 33) may contribute in some way to
the eradication of latent HIV infection, approaches that focus on
latent virus in TCM CD4
 T cells are of the highest priority.
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